Feasibility of Radiofrequency Resection in Oropharyngeal Tumor Surgery
NCT ID: NCT03175770
Last Updated: 2020-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
25 participants
OBSERVATIONAL
2015-01-01
2017-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Goal of this study is to show feasibility and safety of Radiofrequency Resection in Oropharyngeal Tumor Surgery.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiofrequency Ablation for Warthin's Tumor
NCT05078541
Plasma Radiofrequency Ablation at Low Temperature Versus Electrocautery Block Resection at High Frequency for Localized Recurrent Nasopharyngeal Carcinoma
NCT04425265
Radiofrequency Ablation in Treating Patients Who Are Undergoing Surgery for Thyroid Cancer
NCT00103155
The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma
NCT02418390
Improving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance
NCT02405000
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Goal of this study is to show feasibility and safety of Radiofrequency Resection in Oropharyngeal Tumor Surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with benign or malign tumor in the oropharynx
Patient of 18 years and older with benign or malign tumor in the oropharynx. The resection is done transorally by radiofrequency
transoral radiofrequency Resection in Oropharyngeal Tumor Surgery
Patient of 18 years and older with benign or malign tumor in the oropharynx. The resection is done transorally by radiofrequency
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transoral radiofrequency Resection in Oropharyngeal Tumor Surgery
Patient of 18 years and older with benign or malign tumor in the oropharynx. The resection is done transorally by radiofrequency
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clemens Heiser, MD
Role: PRINCIPAL_INVESTIGATOR
department for ENT, Klinikum Rechts der Isar der Technischen Universität München, Ismaninger Straße 22, 81675 München, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ear Nose Throat
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
381/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.